Oppenheimer & Co. Inc. increased its stake in Colgate-Palmolive Company (NYSE:CL) by 2.2% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 55,815 shares of the company’s stock after buying an additional 1,175 shares during the period. Oppenheimer & Co. Inc.’s holdings in Colgate-Palmolive were worth $4,086,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of CL. TIAA CREF Investment Management LLC raised its stake in Colgate-Palmolive by 84.2% in the first quarter. TIAA CREF Investment Management LLC now owns 4,554,989 shares of the company’s stock valued at $333,380,000 after buying an additional 2,082,262 shares during the last quarter. Swiss National Bank raised its stake in Colgate-Palmolive by 22.2% in the first quarter. Swiss National Bank now owns 3,667,072 shares of the company’s stock valued at $268,393,000 after buying an additional 666,400 shares during the last quarter. Karp Capital Management Corp raised its stake in Colgate-Palmolive by 3,749.4% in the first quarter. Karp Capital Management Corp now owns 381,210 shares of the company’s stock valued at $27,901,000 after buying an additional 371,307 shares during the last quarter. Teachers Advisors LLC raised its stake in Colgate-Palmolive by 25.4% in the first quarter. Teachers Advisors LLC now owns 1,814,250 shares of the company’s stock valued at $132,785,000 after buying an additional 367,977 shares during the last quarter. Finally, FIL Ltd raised its stake in Colgate-Palmolive by 42.6% in the first quarter. FIL Ltd now owns 1,092,839 shares of the company’s stock valued at $79,985,000 after buying an additional 326,668 shares during the last quarter. Institutional investors and hedge funds own 73.85% of the company’s stock.

Colgate-Palmolive Company (NYSE:CL) traded down 0.41% during mid-day trading on Friday, hitting $71.26. The stock had a trading volume of 2,023,502 shares. The company has a 50 day moving average price of $72.84 and a 200-day moving average price of $72.74. The company has a market cap of $62.77 billion, a price-to-earnings ratio of 26.48 and a beta of 0.80. Colgate-Palmolive Company has a one year low of $63.43 and a one year high of $77.27.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, July 21st. The company reported $0.72 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.72. Colgate-Palmolive had a net margin of 15.83% and a return on equity of 3,121.95%. The business had revenue of $3.83 billion for the quarter, compared to the consensus estimate of $3.89 billion. During the same quarter last year, the firm posted $0.70 EPS. The business’s revenue for the quarter was down .5% compared to the same quarter last year. Equities analysts expect that Colgate-Palmolive Company will post $2.89 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, August 15th. Investors of record on Tuesday, July 18th will be paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 2.25%. The ex-dividend date is Friday, July 14th. Colgate-Palmolive’s dividend payout ratio (DPR) is 59.48%.

ILLEGAL ACTIVITY NOTICE: “Oppenheimer & Co. Inc. Buys 1,175 Shares of Colgate-Palmolive Company (CL)” was first posted by TheOlympiaReport and is the property of of TheOlympiaReport. If you are viewing this story on another site, it was illegally stolen and reposted in violation of international copyright and trademark legislation. The original version of this story can be viewed at https://theolympiareport.com/2017/08/12/oppenheimer-co-inc-buys-1175-shares-of-colgate-palmolive-company-cl.html.

A number of analysts have issued reports on the company. UBS AG reissued a “neutral” rating and issued a $78.00 target price (down previously from $79.00) on shares of Colgate-Palmolive in a research report on Tuesday, May 2nd. Jefferies Group LLC reissued a “hold” rating and issued a $79.00 target price (up previously from $77.00) on shares of Colgate-Palmolive in a research report on Monday, July 24th. Zacks Investment Research lowered Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Thursday, July 27th. BidaskClub lowered Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Saturday, June 24th. Finally, Royal Bank Of Canada reissued a “hold” rating and issued a $74.00 target price on shares of Colgate-Palmolive in a research report on Thursday, May 25th. Two investment analysts have rated the stock with a sell rating, twelve have given a hold rating and two have assigned a buy rating to the company. Colgate-Palmolive presently has a consensus rating of “Hold” and an average price target of $75.82.

In related news, insider Patricia Verduin sold 3,833 shares of Colgate-Palmolive stock in a transaction on Monday, July 17th. The shares were sold at an average price of $72.41, for a total transaction of $277,547.53. Following the sale, the insider now owns 53,022 shares of the company’s stock, valued at approximately $3,839,323.02. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director John T. Cahill sold 8,000 shares of Colgate-Palmolive stock in a transaction on Thursday, July 27th. The stock was sold at an average price of $72.47, for a total transaction of $579,760.00. Following the sale, the director now directly owns 31,786 shares in the company, valued at approximately $2,303,531.42. The disclosure for this sale can be found here. Insiders have sold a total of 203,969 shares of company stock worth $14,711,068 in the last ninety days. 1.02% of the stock is currently owned by insiders.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with Analyst Ratings Network's FREE daily email newsletter.